160 related articles for article (PubMed ID: 3411688)
1. Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma.
Ellison MF; Mostofi FK; Flanigan RC
J Urol; 1988 Sep; 140(3):618-20. PubMed ID: 3411688
[TBL] [Abstract][Full Text] [Related]
2. Residual mass after chemotherapy for seminoma: changing concepts of management.
Herr HW; Bosl G
J Urol; 1987 Jun; 137(6):1234-5. PubMed ID: 2438431
[TBL] [Abstract][Full Text] [Related]
3. Should chemotherapy replace retroperitoneal lymphadenectomy for clinical stage II testicular tumors?
Swanson DA
Mayo Clin Proc; 1995 Sep; 70(9):911-3. PubMed ID: 7643646
[No Abstract] [Full Text] [Related]
4. [Advanced testicular seminoma: treatment of residual masses after chemotherapy. A review of 3 cases].
Bassoulet J; Guillemot M; Merrer J; Pabot du Chatelard P; Beauvais H; Timbal Y
J Urol (Paris); 1990; 96(1):19-24. PubMed ID: 2313107
[TBL] [Abstract][Full Text] [Related]
5. [A case of bilateral testicular tumors showing remarkable regression of huge metastatic tumors after VAB-6 combined chemotherapy].
Nakashima T; Nakajima K; Yokoyama O; Sugata T; Tokunaga S; Nitta M; Hisazumi H
Hinyokika Kiyo; 1988 Oct; 34(10):1823-8. PubMed ID: 2469323
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.
Dexeus FH; Shirkhoda A; Logothetis CJ; Chong C; Sella A; Ogden S; Swanson D
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):35-43. PubMed ID: 2920767
[TBL] [Abstract][Full Text] [Related]
7. Value of retroperitoneal lymph node dissection in advanced testicular seminoma.
Kamat MR; Kulkarni JN; Tongaonkar HB; Ravi R
J Surg Oncol; 1992 Sep; 51(1):65-7. PubMed ID: 1381455
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
Carter GE; Lieskovsky G; Skinner DG; Daniels JR
J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
[TBL] [Abstract][Full Text] [Related]
9. [Ambulatory carboplatin monotherapy in advanced seminoma].
Dieckmann KP; Bornhoeft G; Huland H
Urologe A; 1990 Sep; 29(5):281-5. PubMed ID: 2219603
[TBL] [Abstract][Full Text] [Related]
10. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
[TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
Fosså SD; Ous S; Lien HH; Stenwig AE
J Urol; 1989 Mar; 141(3):557-9. PubMed ID: 2918591
[TBL] [Abstract][Full Text] [Related]
12. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment.
Fosså SD; Kullmann G; Lien HH; Stenwig AE; Ous S
Br J Urol; 1989 Nov; 64(5):530-4. PubMed ID: 2611626
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of retroperitoneal lymph node swelling by computed tomography in advanced testicular cancer patients, with special reference to retrocrural lymph node swelling].
Kawamura J; Hida S; Higashi Y; Yamauchi T; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1105-16. PubMed ID: 4061213
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative irradiation: another option for the treatment of > or = 3 cm residual mass following chemotherapy for advanced testicular seminoma.
Ravi R; Vasanthan A
Urol Int; 1995; 55(3):137-40. PubMed ID: 8540156
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of advanced seminoma treated with Einhorn's regimen].
Kawano S; Sakoda R; Sakamoto S; Ogata J
Gan No Rinsho; 1985 Apr; 31(4):449-52. PubMed ID: 2409310
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of metastatic seminoma.
Schuette J; Niederle N; Scheulen ME; Seeber S; Schmidt CG
Br J Cancer; 1985 Apr; 51(4):467-72. PubMed ID: 2579665
[TBL] [Abstract][Full Text] [Related]
18. Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
Lerner SE; Mann BS; Blute ML; Richardson RL; Zincke H
Mayo Clin Proc; 1995 Sep; 70(9):821-8. PubMed ID: 7543967
[TBL] [Abstract][Full Text] [Related]
19. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
20. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
Stomper PC; Jochelson MS; Garnick MB; Richie JP
AJR Am J Roentgenol; 1985 Oct; 145(4):743-6. PubMed ID: 3875994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
